TREVI THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.5 USD | -1.57% |
|
-9.75% | +86.57% |
| 07/05 | Transcript : Trevi Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
| 07/05 | Trevi Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TREVI THERAPEUTICS, INC. | Bio Therapeutic Drugs | -1.57% | -9.75% | +86.57% | +2.04% | -72.28% | 18Cr |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- TRVI Stock
- Charts Trevi Therapeutics, Inc.
- Comparison Chart
